For instance, in NSCLC, the mutation frequency of EGFR is markedly higher in Asian populations compared to Caucasian populations, resulting in a greater utilization rate of EGFR-TKIs in Asian NSCLC patients. Here, EGFR is linked to non-small cell lung carcinoma.